Zota Health Care LImited vs Zydus Lifesciences Limited

A side-by-side comparison of Zota Health Care LImited (ZOTA) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Zydus Lifesciences Limited leads ZOTA vs ZYDUSLIFE on 9 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation12
  • Profitability04
  • Growth10
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

ZYDUSLIFE takes 2/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

-36.50
P/E ratio
22.42
5.49
P/B ratio
4.11
0.09%
Dividend yield even
0.09%
₹-22.46
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-10.66%
Return on equity
18.59%
-8.65%
Return on capital
18.07%
3.44%
EBITDA margin
31.22%
-13.75%
Net margin
18.87%

Growth

ZOTA takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

57.07%
Revenue CAGR (3Y)
16.35%
—
Profit CAGR (3Y) even
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4,881 Cr
Market cap
₹1.12L Cr
₹539 Cr
Revenue
₹27,148 Cr
₹-74 Cr
Net profit
₹5,124 Cr
0.04
Debt / equity
0.46
Zota Health Care LImited
  • + ["Company is almost debt free.", "Company has delivered good sales growth of 38.4% CAGR over last 5 years"]
  • − ["Stock is trading at 7.04 times its book value", "Company has a low return on equity of -23.0% over last 3 years.", "Company reported a net loss of ₹74 Cr in its latest financial year."]
Zydus Lifesciences Limited
  • + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
  • − []
Zota Health Care LImited full analysis Zydus Lifesciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.